|
Luis Garcia de Guadiana Romualdo, Mulero MDR, Olivo MH, Rojas CR, Arenas VR, Morales MG, Abellan AB, Conesa-Zamora P, Garcia-Garcia J, Hernandez AC, Morell-Garcia D, Dolores Albaladejo-Oton M, Consuegra-Sanchez L. Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series. J Infect. 2021 Feb;82(2):e40-e42. doi: 10.1016/j.jinf.2020.08.010. Epub 2020 Aug 12. No abstract available. PubMed PMID: 32795482; PubMed Central PMCID: PMC7419246.
AÑO: 2021; IF: 38.637
|
32795482
|
Kondelova A, Alburquerque-Gonzalez B, Vychytilova-Faltejskova P, Garcia-Solano J, Prochazka V, Kala Z, Perez F, Slaby O, Conesa-Zamora P. miR-181a-2* expression is different amongst carcinomas from the colorectal serrated route. Mutagenesis. 2020 Jul 11;35(3):233-241. doi: 10.1093/mutage/gez039. PubMed PMID: 31784758.
AÑO: 2020; IF: 3.0
|
|
Galan-Ros J, Ramos-Arenas V, Conesa-Zamora P. Predictive values of colon microbiota in the treatment response to colorectal cancer. Pharmacogenomics. 2020 Sep;21(14):1045-1059. doi: 10.2217/pgs-2020-0044. Epub 2020 Sep 8. PubMed PMID: 32896201.
AÑO: 2020; IF: 2.533
|
|
Alburquerque-Gonzalez B, Bernabe-Garcia M, Montoro-Garcia S, Bernabe-Garcia A, Rodrigues PC, Ruiz Sanz J, Lopez-Calderon FF, Luque I, Nicolas FJ, Cayuela ML, Salo T, Perez-Sanchez H, Conesa-Zamora P. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells. Exp Mol Med. 2020 Feb;52(2):281-292. doi: 10.1038/s12276-020-0389-x. Epub 2020 Feb 20. PubMed PMID: 32080340; PubMed Central PMCID: PMC7062870.
AÑO: 2020; IF: 8.718
|
|
Manuel Sanchez-Maldonado J, Martinez-Bueno M, Canhao H, Ter Horst R, Munoz-Pena S, Moniz-Diez A, Rodriguez-Ramos A, Escudero A, Sorensen SB, Hetland ML, Ferrer MA, Glintborg B, Filipescu I, Perez-Pampin E, Conesa-Zamora P, Garcia A, den Broeder A, De Vita S, Hove Jacobsen SE, Collantes E, Quartuccio L, Netea MG, Li Y, Fonseca JE, Jurado M, Lopez-Nevot MA, Coenen MJH, Andersen V, Caliz R, Sainz J. NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium. Sci Rep. 2020 Mar 9;10(1):4316. doi: 10.1038/s41598-020-61331-5. PubMed PMID: 32152480; PubMed Central PMCID: PMC7062729.
AÑO: 2020; IF: 4.379
|